Abstract:Background The fraily index is a useful proxy measure of accelerated biological ageing and in estimating all-cause and cause-specific mortality in older individuals in European and US populations. However, the predictive value of the frailty index in other populations outside of Europe and the USA and in adults younger than 50 years is unknown. We aimed to examine the association between the frailty index and mortality in a population of Chinese adults. Methods In this prospective cohort study, we used data from the China Kadoorie Biobank. We included adults aged 30-79 years from ten areas (five urban areas and five rural areas) of China who had no missing values for the items that made up the frailty index. We did not exclude participants on the basis of baseline morbidity status. We calculated the follow-up person-years from the baseline date to either the date of death, loss to follow-up, or Dec 31, 2017, whichever came first, through linkage with the registries of China's Disease Surveillance Points system and local residential records. Active follow-up visits to local communities were done annually for participants who were not linked to any established registries. Causes of death from official death certificates were supplemented, if necessary, by reviewing medical records or doing standard verbal autopsy procedures. The frailty index was calculated using 28 baseline variables, all of which were health status deficits measured by use of questionnaires and physical examination. We defined three categories of frailty status: robust (frailty index <= 010), prefrail (frailty index 010 to < 025), and frail (frailty index >= 025). The primary outcomes were all-cause mortality and cause-specific mortality in Chinese adults aged 30-79 years. We used a Cox proportional hazards model to estimate the associations between the frailty index and all-cause and cause-specific mortality, adjusting for chronological age, education, and lifestyle factors. Findings 512 723 participants, recruited between June 25, 2004, and July 15, 2008, were followed up for a median of 108 years (IQR 102-131; total follow-up 5 551 974 person-years). 291 954 (569%) people were categorised as robust, 205 075 (400%) people were categorised as prefrail, and 15 694 (31%) people were categorised as frail. Women aged between 45 years and 79 years had a higher mean frailty index and a higher prevalence of frailty than did men. During follow-up, 49 371 deaths were recorded. After adjustment for established and potential risk factors for death, each 01 increment in the frailty index was associated with a higher risk of all-cause mortality (hazard ratio [HR] 168, 95% CI 166-171). Such associations were stronger among younger adults than among older adults (p(interaction)< 00001), with HRs per 01 increment of the frailty index of 195 (95% CI 187-203) for those younger than 50 years, 180 (176-183) for those aged 50-64 years, and 156 (153-159) for those 65 years and older. After adjustments, there was no difference between the sexes in the association between the frailty index and all-cause mortality (p(interaction)=075). For each 01 increment of the frailty index, the corresponding HRs for risk of death were 189 (95% CI 183-194) from ischaemic heart disease, 184 (179-189) from cerebrovascular disease, 119 (116-122) from cancer, 254 (245-263) from respiratory disease, 178 (159-200) from infection, and 178 (173-183) from all other causes. Interpretation The frailty index is associated with all-cause and cause-specific mortality independent of chronological age in younger and older Chinese adults. The identification of younger adults with accelerated ageing by use of surrogate measures could be useful for the prevention of premature death and the extension of healthy active life expectancy.

Longitudinal Analysis on Inflammatory Markers and Frailty Progression: Based on the English Longitudinal Study of Aging

C-reactive Protein and White Blood Cell Are Associated with Frailty Progression: a Longitudinal Study

Longitudinal Changes of Cognition and Frailty with All-Cause and Cause-Specific Mortality in Chinese Older Adults: an 11-Year Cohort Study.

Association of Immunity Markers with the Risk of Incident Frailty: the Rugao Longitudinal Aging Study

C-reactive Protein, Frailty and Overnight Hospital Admission in Elderly Individuals: A Population-Based Study.

Inflammatory biomarkers and frailty transitions in older adults with cancer: Findings from a national cohort study.

Association between inflammatory markers, body composition and frailty in home-dwelling elderly: an 8-year follow-up study

Combined Associations of Hs-Crp and Cognitive Function with All-Cause Mortality among Oldest-Old Adults in Chinese Longevity Areas: a Prospective Cohort Study

Frailty detection with routine blood tests using data from the english longitudinal study of ageing (ELSA)

Association of two novel systemic inflammatory biomarkers and frailty based on NHANES 2007–2018

A link between systemic low-grade inflammation and frailty in older adults: clinical evidence from a nationwide population-based study

Inflammatory biomarkers of frailty: A review

Inflammatory markers and physical frailty: towards clinical application

The Association between Dietary Inflammatory Patterns and the Incidence of Frailty and Its Reversal in Older Adults: A Community-Based Longitudinal Follow-Up Study in Taiwan

Frailty Index and All-Cause and Cause-Specific Mortality in Chinese Adults: a Prospective Cohort Study.

Changes in frailty and incident cardiovascular disease in three prospective cohorts

Dietary inflammatory index, mediating biomarkers and incident frailty in Chinese community-dwelling older adults

Changes in Frailty among Community-Dwelling Chinese Older Adults and Its Predictors: Evidence from a Two-Year Longitudinal Study

Frailty index–predicted mortality is moderated by health-related behaviors: a 4-year community-based longitudinal-cohort study

Subclinical cardiovascular disease and frailty risk: the atherosclerosis risk in communities study

Nutritional and inflammation factors associated with current frailty level and effect of co‐morbidities on the progression of frailty